Epigenetic reprogramming promotes the antiviral action of IFNα in HBV-infected cells

Chronic hepatitis B virus (HBV) infections remain a health burden affecting ~250 million people worldwide. Thus far, available interferon-alpha (IFNα)-based therapies have shown unsatisfactory cure rates, and alternative therapeutic molecules are still required. However, their development has been h...

Descripción completa

Detalles Bibliográficos
Autores principales: Gailhouste, Luc, Sudoh, Masayuki, Qin, Xian-Yang, Watashi, Koichi, Wakita, Takaji, Ochiya, Takahiro, Matsuura, Tomokazu, Kojima, Soichi, Furutani, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170866/
https://www.ncbi.nlm.nih.gov/pubmed/34078875
http://dx.doi.org/10.1038/s41420-021-00515-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170866/
https://www.ncbi.nlm.nih.gov/pubmed/34078875
http://dx.doi.org/10.1038/s41420-021-00515-y

Ejemplares similares